Sensitivity Patterns for Patients Diagnosed with CA-MRSA
| Antimicrobial Agent | MIC* | Cases | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | H | I | J | ||
| Amoxicillin/clavulanate | ≥8/4 | R | R | R | R | R | R | R | R | R | R |
| Ampicillin/sulbactam | ≥32 | R | R | – | R | R | R | – | R | R | R |
| Cefazolin | ≥32 | R | R | – | R | R | R | R | R | R | R |
| Ciprofloxacin | ≤0.5/≥4 | S | S | – | S | S | S | S | R | R | R |
| Clindamycin | ≤8 | S | S | S | S | S | S | S | S | S | S |
| Erythromycin | ≥8 | R | R | R | R | R | R | R | R | R | R |
| Gentamycin | ≤2 | – | – | – | – | – | S | – | – | – | S |
| Levofloxacin | ≤1/=4 | S | S | – | S | S | S | – | I | I | I |
| Nitrofurantoin | ≤32 | S | S | – | S | S | S | – | – | S | – |
| Oxacillin | ≥8 | R | R | R | R | R | R | R | R | R | R |
| Penicillin | ≥16 | R | R | R | R | R | R | R | R | R | R |
| Rifampin | ≤1 | S | S | – | S | S | S | – | S | S | S |
| Tetracycline | ≤1 | S | S | – | S | S | S | – | S | S | – |
| Trimethoprim/sulfa | ≤10 | S | S | – | S | S | S | S | S | S | S |
| Vancomycin | ≤0.5 | S | S | S | S | S | S | S | S | S | S |
* MIC, minimal inhibitory concentration; R, resistant; S, sensitive; I, intermediate; -, not reported.